Search research articles
Contact Us
Filters
Showing results (281-290 of 328) with videos related to
Page
of 33
Sort By:
Arthritis and Rheumatism
|
October 19, 2000
The 4G/5G polymorphism of the type 1 plasminogen activator inhibitor gene and thrombosis in patients with antiphospholipid syndrome
D Tàssies, G Espinosa, F J Muñoz-Rodríguez, et al.
Clinical and Experimental Rheumatology
|
January 2, 2003
Low values of creatine kinase in systemic lupus erythematosus. Clinical significance in 300 patients
J Font, M Ramos-Casals, A P Vilas, et al.
Lupus
|
February 10, 2011
Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions
R Cervera, M G Tektonidou, G Espinosa, et al.
Rheumatology (Oxford, England)
|
September 16, 2004
Dementia associated with the antiphospholipid syndrome: clinical and radiological characteristics of 30 patients
J A Gómez-Puerta, R Cervera, L M Calvo, et al.
Lupus
|
June 20, 2007
Antiphospholipid syndrome in Latin American patients: clinical and immunologic characteristics and comparison with European patients
M García-Carrasco, C Galarza, M Gómez-Ponce, et al.
Lupus
|
December 17, 2008
Sixth meeting of the European Forum on antiphospholipid antibodies. How to improve the understanding of the antiphospholipid syndrome?
Z Rotar, B Rozman, P G de Groot, et al.
Lupus
|
June 3, 2016
International multi-center evaluation of a novel chemiluminescence assay for the detection of anti-dsDNA antibodies
C Bentow, G Lakos, P Martis, et al.
Lupus
|
August 28, 2014
Carotid atherosclerosis is not associated with lower bone mineral density and vertebral fractures in patients with systemic lupus erythematosus
C Mendoza-Pinto, M García-Carrasco, M Jiménez-Hernández, et al.
Lupus
|
July 22, 2010
Prolactin's role in the pathogenesis of the antiphospholipid syndrome
S Praprotnik, N Agmon-Levin, B S Porat-Katz, et al.
Lupus
|
December 6, 2012
Safety profile of belimumab: pooled data from placebo-controlled phase 2 and 3 studies in patients with systemic lupus erythematosus
D J Wallace, S Navarra, M A Petri, et al.
Page
of 33
Search research articles
Search
Showing results (281-290 of 328) with videos related to
Sort By:
Page
of 33
Arthritis and Rheumatism
|
October 19, 2000
The 4G/5G polymorphism of the type 1 plasminogen activator inhibitor gene and thrombosis in patients with antiphospholipid syndrome
D Tàssies, G Espinosa, F J Muñoz-Rodríguez, et al.
Clinical and Experimental Rheumatology
|
January 2, 2003
Low values of creatine kinase in systemic lupus erythematosus. Clinical significance in 300 patients
J Font, M Ramos-Casals, A P Vilas, et al.
Lupus
|
February 10, 2011
Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions
R Cervera, M G Tektonidou, G Espinosa, et al.
Rheumatology (Oxford, England)
|
September 16, 2004
Dementia associated with the antiphospholipid syndrome: clinical and radiological characteristics of 30 patients
J A Gómez-Puerta, R Cervera, L M Calvo, et al.
Lupus
|
June 20, 2007
Antiphospholipid syndrome in Latin American patients: clinical and immunologic characteristics and comparison with European patients
M García-Carrasco, C Galarza, M Gómez-Ponce, et al.
Lupus
|
December 17, 2008
Sixth meeting of the European Forum on antiphospholipid antibodies. How to improve the understanding of the antiphospholipid syndrome?
Z Rotar, B Rozman, P G de Groot, et al.
Lupus
|
June 3, 2016
International multi-center evaluation of a novel chemiluminescence assay for the detection of anti-dsDNA antibodies
C Bentow, G Lakos, P Martis, et al.
Lupus
|
August 28, 2014
Carotid atherosclerosis is not associated with lower bone mineral density and vertebral fractures in patients with systemic lupus erythematosus
C Mendoza-Pinto, M García-Carrasco, M Jiménez-Hernández, et al.
Lupus
|
July 22, 2010
Prolactin's role in the pathogenesis of the antiphospholipid syndrome
S Praprotnik, N Agmon-Levin, B S Porat-Katz, et al.
Lupus
|
December 6, 2012
Safety profile of belimumab: pooled data from placebo-controlled phase 2 and 3 studies in patients with systemic lupus erythematosus
D J Wallace, S Navarra, M A Petri, et al.
Page
of 33